:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Jiaqi Tong, Chao Cheng, Guangyu Tong, Michael O. Harhay, Fan Li
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Statistics in Medicine
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1002/sim.70297
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
di: Xi Fang, et al.
Pubblicazione: (2026)

Model‐Robust Standardization in Cluster‐Randomized Trials
di: Fan Li, et al.
Pubblicazione: (2025)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
di: Alessandro Gasparini, et al.
Pubblicazione: (2025)

Causal Inference With Outcomes Truncated by Death and Missing Not at Random
di: Wei Li, et al.
Pubblicazione: (2025)

Moving Toward Best Practice When Using Propensity Score Weighting in Survey Observational Studies
di: Yukang Zeng, et al.
Pubblicazione: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
di: Hao Wang, et al.
Pubblicazione: (2026)

What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies
di: Brennan C. Kahan, et al.
Pubblicazione: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
di: Zhe Chen, et al.
Pubblicazione: (2026)

Doubly robust estimation and sensitivity analysis with outcomes truncated by death in multi-arm clinical trials
di: Tong, Jiaqi, et al.
Pubblicazione: (2024)

Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk Analysis
di: Patrick van Hage, et al.
Pubblicazione: (2025)

The Role of Congeniality in Multiple Imputation for Doubly Robust Causal Estimation
di: Lucy D'Agostino McGowan
Pubblicazione: (2026)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
di: Erik W. van Zwet, et al.
Pubblicazione: (2026)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
di: Xinran Huang, et al.
Pubblicazione: (2024)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
di: Kendra Davis‐Plourde, et al.
Pubblicazione: (2025)

Futility Monitoring in Clinical Trials
di: Ana M. Ortega‐Villa, et al.
Pubblicazione: (2025)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
di: Yuwei Cheng, et al.
Pubblicazione: (2026)

Causal Rule Ensemble Approach for Multi‐Arm Data
di: Ke Wan, et al.
Pubblicazione: (2026)

A Tutorial on Implementing Statistical Methods for Estimating Excess Death With a Case Study and Simulations on Estimating Excess Death in the Post‐ COVID ‐19 United States
di: Lillian Rountree, et al.
Pubblicazione: (2026)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
di: Tianyu Zhan, et al.
Pubblicazione: (2026)

Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
di: Jiashan He, et al.
Pubblicazione: (2026)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
di: Yichen Yan, et al.
Pubblicazione: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
di: M. C. Donohue, et al.
Pubblicazione: (2025)

Bayesian Sensitivity Analysis for Causal Estimation With Time‐Varying Unmeasured Confounding
di: Yushu Zou, et al.
Pubblicazione: (2026)

Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example
di: Mikail Nourredine, et al.
Pubblicazione: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
di: Yuan Li, et al.
Pubblicazione: (2025)

A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design
di: Cyrus Mehta, et al.
Pubblicazione: (2025)

Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes
di: Seungjae Lee, et al.
Pubblicazione: (2024)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
di: Ruoyuan Qian, et al.
Pubblicazione: (2025)

What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research
di: Stephen Salerno, et al.
Pubblicazione: (2025)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
di: Xi Fang, et al.
Pubblicazione: (2025)

Interconnections of Multimorbidity‐Related Clinical Outcomes: Analysis of Health Administrative Claims Data With a Dynamic Network Approach
di: Hao Mei, et al.
Pubblicazione: (2025)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
di: Ethan Ashby, et al.
Pubblicazione: (2025)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
di: Kim May Lee, et al.
Pubblicazione: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
di: Xiaotian Chen, et al.
Pubblicazione: (2025)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
di: Holger Dette, et al.
Pubblicazione: (2025)

RMST for Interval‐Censored Data in Oncology Clinical Trials
di: Xiyuan Gao, et al.
Pubblicazione: (2025)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
di: Scott R. Evans, et al.
Pubblicazione: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
di: Elizabeth L. Turner, et al.
Pubblicazione: (2026)

An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis
di: Ke Yang, et al.
Pubblicazione: (2025)

Simultaneous Representation Learning of Multi‐Omics and Clinical Outcome Data via a Supervised Knowledge‐Guided Bayesian Factor Model
di: Qiyiwen Zhang, et al.
Pubblicazione: (2026)